Glucosamine Hydrochloride & Chondroitin Sulfate (500 mg/400 mg) Tablets
Glucosamine Hydrochloride & Chondroitin Sulfate (500 mg/400 mg) Tablets, NPN 80066584: natural health product licensed in Canada. Medicinal ingredients: Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose, Sulfate de chondroïtine.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Chlorhydrate de glucosamine | 500 milligramme | Not calculated |
| Sulfate de chondroïtine | 400 milligramme | Not calculated |
Non-medicinal ingredients
Microcrystalline cellulose, Povidone, Silicon dioxide, Pharmaceutical glaze, Stearic acid, Beta Vulgaris (Beet) Root Extract, Magnesium stearate
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adults | Not specified | 3 tablet | 1 daily |
Uses authorised in Canada
A factor in maintaining healthy cartilage. Helps to maintain healthy cartilage. A factor in maintaining joint health. Helps to maintain joint health. Helps to relieve joint pain associated with osteoarthritis. elps to relieve pain associated with osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
No statement is required.
- Précautions et mises en garde
Consult a health care practitioner if symptoms worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding.
- Effets indésirables connus
No statement is required.
Product record
- Other names
- Glucosamine Hydrochloride & Chondroitin Sulfate (500 mg/400 mg) double Strength Tablets
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80066584
- Status
- Inactive licence
- Licence date
- 25 January 2016
- Revision date
- 18 May 2022
- Form
- Tablet
- Route of administration
- Oral
- Application type
- Compendial
Source
Official Health Canada record, licence 80066584
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Glucosamine Hydrochloride & Chondroitin Sulfate (500 mg/400 mg) Tablets (BIOVANTEK): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80066584-glucosamine-hydrochloride-chondroitin-sulfate-500-mg-400-mg, updated 18 May 2022.